Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The objective of this trial is to define the minimum effective dose of BF 2.649 between 5 mg, 10 mg, 20 mg or 40 mg versus placebo in reducing the Excessive Daytime Sleepiness of Parkinson's disease patients
Critère d'inclusion
- Excessive Daytime Sleepiness ,Parkinson's disease